Results
2
2 companies
Neuren Pharmaceuticals
Market Cap: AU$1.8b
A biopharmaceutical company, develops drugs for the treatment of neurological disorders.
NEU
AU$14.05
7D
9.6%
1Y
-39.2%
EZZ Life Science Holdings
Market Cap: AU$71.5m
Engages in formulation, production, marketing, and sale of the health and wellbeing products in Australia, New Zealand, Mainland China, and internationally.
EZZ
AU$1.52
7D
-12.9%
1Y
53.0%